|
|
|
Michael McCrory, Chairman & CEO
Mr. McCrory has worked in the securities industry since 1995, prior to which he spent over 10 years as an executive in the insurance
industry. He has lived in Italy since 1994 and worked with institutional investors throughout
Europe. In addition to serving in his capacity at I-Bankers Securities he serves on the Board of Directors of various other
companies. Mr. McCrory has been securities licensed since 1992 and holds both a Series 7 and Series 24
license. He holds a BSBA from the University of Phoenix and an MBA from the Owen Graduate School of Management at Vanderbilt University. |
|
| |
|
Shelley Gluck, President
Since 1980, Ms. Gluck has served in various capacities for operations, finance, and compliance in the insurance and securities
industry, including four years as CFO and Director for Commercial Life & Accident Insurance Co. Her BS degree in International Business is from Regents College and her MBA is from Southern Methodist University. She holds Series 7, 24, 27 and 63 securities licenses and serves as Financial Principal for the
firm. |
|
| |
|
Paolo Floriani, Chief European
Advisor, Director
After achieving a master's degree in Management and Auditing from Bocconi University in
Milan, Mr. Floriani spent six years as Director of Investments of
PRIVEST. During 1991 he became a Qualified Swiss Corporate Advisor and
Trustee, and acted as partner and director in many international holding and finance
corporations. His experience includes banking, corporate finance, and real estate
investments. A native Italian, Mr. Floriani brings an extensive European client base. |
|
| |
|
Jean-Pierre Labaune, Advisor
Jean-Pierre Labaune has worked in the pharmaceutical area since
1975. He is a pharmacist trained in non clinical and clinical
pharmacology. Jean-Pierre has served as Research & Development
engineer in big pharmaceutical companies for 20 years. Then, he
moved to the Consulting field in France and Switzerland. He
found his own Consulting company in 2009. Based on his broad and
wide experience and expertise, Jean-Pierre offers technical support
and assistance to the pharmaceutial industry. With IBS group, he
provides unique services to biopharmaceutical companies with the
goal of helping them raise funds and find investors. |
|
| |
|
John Kallassy, Managing
Director, Head of Investment Banking U.S.
Mr. Kallassy possesses more than two decades of M&A, financial
and operations experience as an executive in the healthcare and
technology fields. In his role as CEO of Zargis Medical Corp., Mr.
Kallassy led the global launch of a new medical device that was
awarded "2009 Product of the Year" by Popular Science
magazine. In April 2011, Mr. Kallassy sold Zargis technology to 3M
Corp.. Mr. Kallassy was also the founder and CEO of American Data
Consultants, an information services provider which he sold to R.L.
Polk in 1997. He holds biology and chemistry degrees from the State
University of New York, studied pharmacology at University of Leeds,
and received an MBA from the Johnson School of Management at Cornell
University. |
|
| |
|
John Hurd, Compliance Advisor
Mr. Hurd has been working in the financial services sector,
brokerage, investment advisory and regulatory industries for over
fifteen years. Previously, Mr. Hurd was a Supervisor of Examiners at
FINRA where ha managed examinations of FINRA member firms and
conducted enforcement cases jointly with the Justice Department and
Federal Bureau of Investigations. Mr. Hurd also served as Senior
Adjunct Professor in Banking and Finance for Dowling College,
Townsend School of Business. Mr. Hurd earned both his bachelor's
degree and master's degree from Dowling College in accounting and
banking and finance, respectively. He holds the Series 7, 24, 27,
53, 55, 63, and 66 licences. |
|
|
|
|
|
